Micrometastases predict relapse and survival in high-risk breast cancer
This article has no abstract so we have provided the first paragraph of the full text.
A recent study has demonstrated that the presence of circulating micrometastases, detected using real-time polymerase chain reaction assays for a panel of breast cancer-specific mRNA transcripts, predicts relapse and death in patients with high-risk breast cancer (HRBC) undergoing high-dose chemotherapy after receiving adjuvant chemotherapy.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.